Spinal surgery bleeding: which dose of TXA works best?
NCT ID NCT07288697
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested two doses of the drug tranexamic acid (TXA) in 62 adults undergoing multilevel spinal surgery. The goal was to see which dose better reduces blood loss and the need for blood transfusions. Results could help surgeons choose the safest and most effective dose.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tranexamic acid (TXA)
- What this could lead to
- If successful, this could help determine the best dose of tranexamic acid to reduce blood loss and transfusions during spinal surgery.
- What could go wrong
- This is a small, completed trial with only 62 participants. Results may not apply to all patients or surgeries, and dosing differences may not lead to clear benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD LOSS, SURGICAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kartal Dr. Lütfi Kırdar Şehir Hastanesi
Istanbul, 34865, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A drug that may curb bleeding during fibroid surgery faces its first big test
- Which drug cuts C-Section bleeding best? tranexamic acid vs misoprostol put to the test
- Anesthesia choice may influence blood loss in hip fracture surgery
- Can a simple drug cut blood loss in kids with CP after hip surgery?
- Could a single drug replace the standard cocktail for C-Section bleeding?
- Spine surgery breakthrough? bone marrow clot may speed up fusion